Interpretation of the in-depth analysis of the latest national version of the national drug renewal rules

Recently, the industry has circulated a "Notice on Doing a Good Job in Continuing Work After the Expiry of the National Organizational Drug Centralized Purchase Agreement" (Draft for Solicitation of Comments).

1.

2.

At present, the renewal methods of nationally sourced products are still different in different regions: Hubei Province adopts the method of "inquiry before bidding", according to whether there is a new review situation, and the introduction of unselected original research drugs is based on the lower price of the original selected.

However, the "Notice" clearly requires that, in principle, all nationally-sourced drugs should continue to carry out centralized and volume procurement.

Third, the new argument for competition under classified procurement

The "Notice" puts forward a new view on variety competition, as shown in the figure below

It can be clearly seen from the above figure that the varieties with insufficient competition mainly refer to the varieties that produce equal results and the market competition pattern has changed

It is worth noting that the varieties selected by five or less and the difference is a variety that forms a certain market competition pattern, but the formation of a certain market competition pattern does not mean that sufficient competition has been formed.

In the above chart, the author recommends that you pay attention to the process of price changes.

4.

At present, in order to expand the radiation effect of centralized drug procurement organized by the state, so that patients can enjoy the benefits of large-volume drug procurement, for other unselected drugs that have been purchased online in the province, the basic requirement must be based on the selected price.

According to the requirements of the latest five batches and six rounds of national procurement rules, if the actual number of companies selected in the country is 1 or 2, the current round of procurement cycle is in principle 1 year; if the actual number of companies selected in the country is 3, the current round of procurement cycle is in principle 2 years; if the actual number of selected companies in the country is 4 or more, the current round of procurement cycle is in principle 3 years

The "Notice" finally mentioned that as the price of medical services is gradually adjusted in place, the balance retention ratio can be moderately adjusted and maintained at around 20%-30%